Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Biol Chem
2012 Aug 17;28734:28975-85. doi: 10.1074/jbc.M112.372094.
Show Gene links
Show Anatomy links
Mutations in the GlyT2 gene (SLC6A5) are a second major cause of startle disease.
Carta E
,
Chung SK
,
James VM
,
Robinson A
,
Gill JL
,
Remy N
,
Vanbellinghen JF
,
Drew CJ
,
Cagdas S
,
Cameron D
,
Cowan FM
,
Del Toro M
,
Graham GE
,
Manzur AY
,
Masri A
,
Rivera S
,
Scalais E
,
Shiang R
,
Sinclair K
,
Stuart CA
,
Tijssen MA
,
Wise G
,
Zuberi SM
,
Harvey K
,
Pearce BR
,
Topf M
,
Thomas RH
,
Supplisson S
,
Rees MI
,
Harvey RJ
.
???displayArticle.abstract???
Hereditary hyperekplexia or startle disease is characterized by an exaggerated startle response, evoked by tactile or auditory stimuli, leading to hypertonia and apnea episodes. Missense, nonsense, frameshift, splice site mutations, and large deletions in the human glycine receptor α1 subunit gene (GLRA1) are the major known cause of this disorder. However, mutations are also found in the genes encoding the glycine receptor β subunit (GLRB) and the presynaptic Na(+)/Cl(-)-dependent glycine transporter GlyT2 (SLC6A5). In this study, systematic DNA sequencing of SLC6A5 in 93 new unrelated human hyperekplexia patients revealed 20 sequence variants in 17 index cases presenting with homozygous or compound heterozygous recessive inheritance. Five apparently unrelated cases had the truncating mutation R439X. Genotype-phenotype analysis revealed a high rate of neonatal apneas and learning difficulties associated with SLC6A5 mutations. From the 20 SLC6A5 sequence variants, we investigated glycine uptake for 16 novel mutations, confirming that all were defective in glycine transport. Although the most common mechanism of disrupting GlyT2 function is protein truncation, new pathogenic mechanisms included splice site mutations and missense mutations affecting residues implicated in Cl(-) binding, conformational changes mediated by extracellular loop 4, and cation-π interactions. Detailed electrophysiology of mutation A275T revealed that this substitution results in a voltage-sensitive decrease in glycine transport caused by lower Na(+) affinity. This study firmly establishes the combination of missense, nonsense, frameshift, and splice site mutations in the GlyT2 gene as the second major cause of startle disease.
Al-Owain,
Novel mutation in GLRB in a large family with hereditary hyperekplexia.
2012, Pubmed
Al-Owain,
Novel mutation in GLRB in a large family with hereditary hyperekplexia.
2012,
Pubmed
Bajaj,
Stereochemical criteria for prediction of the effects of proline mutations on protein stability.
2007,
Pubmed
Bakker,
Startle syndromes.
2006,
Pubmed
Bakker,
Clonazepam is an effective treatment for hyperekplexia due to a SLC6A5 (GlyT2) mutation.
2009,
Pubmed
Bartholomäus,
Glycine transporter dimers: evidence for occurrence in the plasma membrane.
2008,
Pubmed
Becker,
Identification of the microdeletion breakpoint in a GLRA1null allele of Turkish hyperekplexia patients.
2006,
Pubmed
Ben-Yona,
A glutamine residue conserved in the neurotransmitter:sodium:symporters is essential for the interaction of chloride with the GABA transporter GAT-1.
2011,
Pubmed
,
Xenbase
Charlier,
Highly effective SNP-based association mapping and management of recessive defects in livestock.
2008,
Pubmed
Chung,
Pathophysiological mechanisms of dominant and recessive GLRA1 mutations in hyperekplexia.
2010,
Pubmed
Davies,
The glycinergic system in human startle disease: a genetic screening approach.
2010,
Pubmed
Dunbrack,
Rotamer libraries in the 21st century.
2002,
Pubmed
Eswar,
Tools for comparative protein structure modeling and analysis.
2003,
Pubmed
Eulenburg,
Mutations within the human GLYT2 (SLC6A5) gene associated with hyperekplexia.
2006,
Pubmed
Forrest,
Identification of a chloride ion binding site in Na+/Cl -dependent transporters.
2007,
Pubmed
Gill,
Startle disease in Irish wolfhounds associated with a microdeletion in the glycine transporter GlyT2 gene.
2011,
Pubmed
Gomeza,
Deletion of the mouse glycine transporter 2 results in a hyperekplexia phenotype and postnatal lethality.
2003,
Pubmed
Harvey,
The genetics of hyperekplexia: more than startle!
2008,
Pubmed
Harvey,
The GDP-GTP exchange factor collybistin: an essential determinant of neuronal gephyrin clustering.
2004,
Pubmed
Ju,
Zn2+ inhibits glycine transport by glycine transporter subtype 1b.
2004,
Pubmed
,
Xenbase
Lobley,
pGenTHREADER and pDomTHREADER: new methods for improved protein fold recognition and superfamily discrimination.
2009,
Pubmed
Mager,
Measurement of transient currents from neurotransmitter transporters expressed in Xenopus oocytes.
1998,
Pubmed
,
Xenbase
Manzke,
Serotonin receptor 1A-modulated phosphorylation of glycine receptor α3 controls breathing in mice.
2010,
Pubmed
Mitchell,
Structure and function of extracellular loop 4 of the serotonin transporter as revealed by cysteine-scanning mutagenesis.
2004,
Pubmed
Nigro,
Hyperekplexia and sudden neonatal death.
1992,
Pubmed
Norregaard,
Delineation of an endogenous zinc-binding site in the human dopamine transporter.
1998,
Pubmed
Rees,
Mutations in the gene encoding GlyT2 (SLC6A5) define a presynaptic component of human startle disease.
2006,
Pubmed
,
Xenbase
Rees,
Isoform heterogeneity of the human gephyrin gene (GPHN), binding domains to the glycine receptor, and mutation analysis in hyperekplexia.
2003,
Pubmed
Rees,
Hyperekplexia associated with compound heterozygote mutations in the beta-subunit of the human inhibitory glycine receptor (GLRB).
2002,
Pubmed
Rousseau,
The glycine transporter GlyT2 controls the dynamics of synaptic vesicle refilling in inhibitory spinal cord neurons.
2008,
Pubmed
Roux,
Neuronal and glial glycine transporters have different stoichiometries.
2000,
Pubmed
,
Xenbase
Roux,
The glial and the neuronal glycine transporters differ in their reactivity to sulfhydryl reagents.
2001,
Pubmed
,
Xenbase
Shen,
Statistical potential for assessment and prediction of protein structures.
2006,
Pubmed
Shiang,
Mutations in the alpha 1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia.
1993,
Pubmed
Shiang,
Mutational analysis of familial and sporadic hyperekplexia.
1995,
Pubmed
Singh,
A competitive inhibitor traps LeuT in an open-to-out conformation.
2008,
Pubmed
Sirén,
Hyperekplexia in Kurdish families: a possible GLRA1 founder mutation.
2006,
Pubmed
Söding,
The HHpred interactive server for protein homology detection and structure prediction.
2005,
Pubmed
Stalder,
The meaning of nonsense.
2008,
Pubmed
Vigevano,
Startle disease: an avoidable cause of sudden infant death.
1989,
Pubmed
Yamashita,
Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters.
2005,
Pubmed
Zeilhofer,
Glycinergic neurons expressing enhanced green fluorescent protein in bacterial artificial chromosome transgenic mice.
2005,
Pubmed
Zomot,
The interaction of the gamma-aminobutyric acid transporter GAT-1 with the neurotransmitter is selectively impaired by sulfhydryl modification of a conformationally sensitive cysteine residue engineered into extracellular loop IV.
2003,
Pubmed
,
Xenbase
Zomot,
Mechanism of chloride interaction with neurotransmitter:sodium symporters.
2007,
Pubmed